Log in to save to my catalogue

Novel Pharmacological Targets of Post-Traumatic Stress Disorders

Novel Pharmacological Targets of Post-Traumatic Stress Disorders

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_2b11db52727744a085b23644bf08b0a0

Novel Pharmacological Targets of Post-Traumatic Stress Disorders

About this item

Full title

Novel Pharmacological Targets of Post-Traumatic Stress Disorders

Publisher

Basel: MDPI AG

Journal title

Life (Basel, Switzerland), 2023-08, Vol.13 (8), p.1731

Language

English

Formats

Publication information

Publisher

Basel: MDPI AG

More information

Scope and Contents

Contents

Post-traumatic stress disorder (PTSD) is a psychopathological condition with a heterogeneous clinical picture that is complex and challenging to treat. Its multifaceted pathophysiology still remains an unresolved question and certainly contributes to this issue. The pharmacological treatment of PTSD is mainly empirical and centered on the serotoner...

Alternative Titles

Full title

Novel Pharmacological Targets of Post-Traumatic Stress Disorders

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_2b11db52727744a085b23644bf08b0a0

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_2b11db52727744a085b23644bf08b0a0

Other Identifiers

ISSN

2075-1729

E-ISSN

2075-1729

DOI

10.3390/life13081731

How to access this item